An epitope vaccine derived by analyzing clinical trial samples safeguards hosts with prior exposure to S. aureus against reinfection | Science Translational Medicine
An epitope vaccine based on MntC prevents Staphylococcus aureus infection in mice with prior exposure-induced, nonprotective immune imprints.
